Cargando…

Normal tissue architecture determines the evolutionary course of cancer

Cancer growth can be described as a caricature of the renewal process of the tissue of origin, where the tissue architecture has a strong influence on the evolutionary dynamics within the tumor. Using a classic, well-studied model of tumor evolution (a passenger-driver mutation model) we systematica...

Descripción completa

Detalles Bibliográficos
Autores principales: West, Jeffrey, Schenck, Ryan O., Gatenbee, Chandler, Robertson-Tessi, Mark, Anderson, Alexander R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024392/
https://www.ncbi.nlm.nih.gov/pubmed/33824323
http://dx.doi.org/10.1038/s41467-021-22123-1
_version_ 1783675303562838016
author West, Jeffrey
Schenck, Ryan O.
Gatenbee, Chandler
Robertson-Tessi, Mark
Anderson, Alexander R. A.
author_facet West, Jeffrey
Schenck, Ryan O.
Gatenbee, Chandler
Robertson-Tessi, Mark
Anderson, Alexander R. A.
author_sort West, Jeffrey
collection PubMed
description Cancer growth can be described as a caricature of the renewal process of the tissue of origin, where the tissue architecture has a strong influence on the evolutionary dynamics within the tumor. Using a classic, well-studied model of tumor evolution (a passenger-driver mutation model) we systematically alter spatial constraints and cell mixing rates to show how tissue structure influences functional (driver) mutations and genetic heterogeneity over time. This approach explores a key mechanism behind both inter-patient and intratumoral tumor heterogeneity: competition for space. Time-varying competition leads to an emergent transition from Darwinian premalignant growth to subsequent invasive neutral tumor growth. Initial spatial constraints determine the emergent mode of evolution (Darwinian to neutral) without a change in cell-specific mutation rate or fitness effects. Driver acquisition during the Darwinian precancerous stage may be modulated en route to neutral evolution by the combination of two factors: spatial constraints and limited cellular mixing. These two factors occur naturally in ductal carcinomas, where the branching topology of the ductal network dictates spatial constraints and mixing rates.
format Online
Article
Text
id pubmed-8024392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80243922021-04-21 Normal tissue architecture determines the evolutionary course of cancer West, Jeffrey Schenck, Ryan O. Gatenbee, Chandler Robertson-Tessi, Mark Anderson, Alexander R. A. Nat Commun Article Cancer growth can be described as a caricature of the renewal process of the tissue of origin, where the tissue architecture has a strong influence on the evolutionary dynamics within the tumor. Using a classic, well-studied model of tumor evolution (a passenger-driver mutation model) we systematically alter spatial constraints and cell mixing rates to show how tissue structure influences functional (driver) mutations and genetic heterogeneity over time. This approach explores a key mechanism behind both inter-patient and intratumoral tumor heterogeneity: competition for space. Time-varying competition leads to an emergent transition from Darwinian premalignant growth to subsequent invasive neutral tumor growth. Initial spatial constraints determine the emergent mode of evolution (Darwinian to neutral) without a change in cell-specific mutation rate or fitness effects. Driver acquisition during the Darwinian precancerous stage may be modulated en route to neutral evolution by the combination of two factors: spatial constraints and limited cellular mixing. These two factors occur naturally in ductal carcinomas, where the branching topology of the ductal network dictates spatial constraints and mixing rates. Nature Publishing Group UK 2021-04-06 /pmc/articles/PMC8024392/ /pubmed/33824323 http://dx.doi.org/10.1038/s41467-021-22123-1 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
West, Jeffrey
Schenck, Ryan O.
Gatenbee, Chandler
Robertson-Tessi, Mark
Anderson, Alexander R. A.
Normal tissue architecture determines the evolutionary course of cancer
title Normal tissue architecture determines the evolutionary course of cancer
title_full Normal tissue architecture determines the evolutionary course of cancer
title_fullStr Normal tissue architecture determines the evolutionary course of cancer
title_full_unstemmed Normal tissue architecture determines the evolutionary course of cancer
title_short Normal tissue architecture determines the evolutionary course of cancer
title_sort normal tissue architecture determines the evolutionary course of cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024392/
https://www.ncbi.nlm.nih.gov/pubmed/33824323
http://dx.doi.org/10.1038/s41467-021-22123-1
work_keys_str_mv AT westjeffrey normaltissuearchitecturedeterminestheevolutionarycourseofcancer
AT schenckryano normaltissuearchitecturedeterminestheevolutionarycourseofcancer
AT gatenbeechandler normaltissuearchitecturedeterminestheevolutionarycourseofcancer
AT robertsontessimark normaltissuearchitecturedeterminestheevolutionarycourseofcancer
AT andersonalexanderra normaltissuearchitecturedeterminestheevolutionarycourseofcancer